Jan 29, 2026

Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics:

• AKT inhibitors for PTEN-deficient de novo metastatic hormone-sensitive prostate cancer (0:00)
• Radioligand-directed therapy for PSMA-positive metastatic hormone-sensitive prostate cancer (8:18)
• Radiation therapy in combination with enzalutamide for high-risk localized prostate cancer (13:14)

CME information and select publications